Trials / Withdrawn
WithdrawnNCT02024269
Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Injected Intravitreal in Dry Macular Degeneration
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bioheart, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This will be an open-label, non-randomized multi-center study of adipose stem cell (ASC) implantation. ASCs will be derived from the patient's adipose or fat. Liposuction using local anesthesia and syringe collection will be performed to collect the adipose tissue specimen for subsequent processing to isolate the stem cells. The cells will be delivered via needle injection into the eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Adipose Derived Stem Cells |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2016-12-01
- Completion
- 2017-06-01
- First posted
- 2013-12-31
- Last updated
- 2015-09-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02024269. Inclusion in this directory is not an endorsement.